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Abstract: It is a common clinical experience that patients with chronic obstructive   pulmonary 
disease (COPD) complain of airway symptoms provoked by environmental irritants like chemicals 
and scents, although few studies can confirm such connections. The aim was to study the 
prevalence of airway symptoms induced by chemicals and scents in a group of patients with newly 
diagnosed CPOD and to analyze any relation to illness severity and quality of life. Eighty-one 
patients with COPD were recruited to the study. By mail they were asked to answer three 
questionnaires regarding symptoms, quality of life, and social and emotional influence of airway 
symptoms induced by environmental irritants. A majority (62%) of the COPD patients claimed 
to be hyperreactive to chemicals and scents. As a group they scored higher on a questionnaire 
measuring social and emotional influences of such environmental irritants compared to healthy 
control subjects. Further, high scores were more common among patients with a very severe form 
of COPD and among patients with regular use of β2-stimulants. High scores were also associated 
with significantly more airway symptoms and, in some aspects, with impaired quality of life. 
In conclusion, the results of this study show that airway symptoms induced by environmental 
irritants are common in patients with COPD and that this increased airway sensitivity follows 
the impairment of lung capacity. The mechanisms behind this remain unclear.
Keywords: COPD, hyperresponsiveness, environmental irritants, sensory hyperreactivity, 
quality of life
Introduction
It is a common clinical experience that patients with chronic obstructive pulmonary 
disease (COPD) complain of airway symptoms provoked by environmental irritants 
like chemicals and scents, although few studies can confirm such connections. An 
indirect method to measure sensory nerve responsiveness to environmental irritants is 
to measure the cough outcome to inhaled capsaicin.1,2 Capsaicin (8-methyl-N-vanillyl-
6-nonenamide), the ingredient that produces the heat in hot chili, is a well-known 
cough-inducing agent when inhaled.2,3 Cough reflex sensitivity to capsaicin in patients 
with COPD has been recorded in only a few studies with small groups of patients, and 
was reported to be normal or increased.4–6
Upper and lower airway symptoms induced by chemicals and scents is a frequent 
problem in society, and sometimes the experienced symptoms are excessive, leading 
individuals to seek health care.7,8 In a subgroup of patients without COPD, asthma, or 
allergy, such symptoms in combination with increased cough sensitivity to inhaled 
capsaicin, known to stimulate the airway sensory nerves, have been identified.9,10 International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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A suggested name for the condition is “sensory hyperre-
activity (SHR),” and it affects more than 6% of the adult 
population in Sweden.11
The Chemical Sensitivity Scale for SHR (CSS-SHR) 
was developed in order to quantify self-reported affective 
reactions to and behavioral disruptions by odorous/pungent 
substances.12 The eleven items of the CSS-SHR were found 
to generate approximately normal distributions, have good 
test-retest reliability, good internal consistency and predic-
tive and concurrent validity, and to be unidimensional. The 
metric properties were satisfying despite the few items. In a 
random general population of adults, the prevalence of such 
problems, defined as a CSS-SHR score $ 43, was 19% with 
an increased risk for female gender (odds ratio = 2.3).13
There are a lot of studies on quality of life in COPD; 
the instruments to measure this could simply be divided 
into either generic or disease-specific health measures.14 
The Nottingham Health Profile (NHP) is a well-known and 
well-tested generic measure instrument that has been used 
for a number of different conditions to measure the “impact 
on well-being” – how disease and symptoms affect the 
patient’s health, well-being, and ability to function in daily 
life.15,16 NHP, which focuses on questions concerning patients 
suffering from different chronic illnesses, has been shown to 
have both high validity as well as reliability.17 In COPD, the 
NHP showed strong relation to clinical and physical param-
eters.18,19 Bilingual health care personnel have translated the 
NHP from English to Swedish, with the aim of expressing 
how patients experience the effects of illness, as stated in 
their own words.
The aim was to study the prevalence of airway symp-
toms induced by chemicals and scents in a group of patients 
with newly diagnosed CPOD and to analyze any relation to 
illness severity. Further, the aim was to measure the social 
and emotional influence of airway symptoms induced by 
  environmental irritants in COPD and to study if any influence 
is related to quality of life.
Methods
Participants
From the Department of Respiratory Medicine and Allergy at 
the Sahlgrenska University Hospital in Gothenburg, Sweden, 
124 consecutive patients between 40–75 years of age were 
invited by mail to take part in the study. A pilot group of 18 
patients was recruited from August 1, 2005 to October 31, 
2005 and the rest of the data were collected from June 1, 
2006 to September 18, 2007. All patients had a new diagno-
sis of COPD and were originally referred to the clinic due 
to increasing respiratory symptoms. The patients fulfilled 
international criteria for COPD20 and had the diagnosis code 
for COPD set by a doctor specializing in pulmonary diseases. 
The patients were reminded once to complete the question-
naire, and in some cases, at patient request, new question-
naires were sent out or patients were phoned to complete 
answers. After this, 26 had not answered and 17 informed 
that they did not want to take part in the study, leaving 
81 responders (65%). All patients had smoked for more than 
10 years and 17 were still smokers. Demographic data are 
given in Table 1.
Questionnaires
Three questionnaires were sent by mail to the patients with 
a covering letter, informed consent form, and a prepaid 
envelope. The patients were asked to answer the questions 
according to their actual current condition.
1.	 The participants were asked to evaluate symptoms on 
a scale of 0–3 (0 = no symptoms, 1 = mild symptoms, 
2 = moderate symptoms, and 3 = severe symptoms). Seven 
symptoms were analyzed: heavy breathing, difficulty 
to get air, cough, chest pressure, phlegm, hoarseness, 
Table 1 Demographic data for 81 patients with chronic obstructive pulmonary disease; median values and ranges, within brackets, 
are given
Male/female 
(%)
Age 
(years)
Pack years FEV1 
(% pred)
FVC 
(% pred)
FEV1% *AC 
(%)
*ICS 
(%)
*β2-stim 
(%)
43/38 66 
(47–75)
38 
(6–90)
48 
(16–84)
84 
(36–122)
46 
(19–78)
77 73 65
Severity of COPD
Mild 
FEV1 $ 80% pred
Moderate 
FEV1 50%–80% pred
Severe 
FEV1 30%–50% pred
Very severe 
FEV1 , 30% pred
number 2 33 35 11
Note: *receiving regular treatment with anticholinergics, inhaled corticosteroids, β2-stimulants.
Abbreviations: AC, anticholinergics; β2-stim, β2-stimulants; FeV1, forced expiratory volume in 1 second; FeV1%, ratio of forced expiratory volume in 1 second to forced 
vital capacity; FVC, forced vital capacity; ICs, inhaled corticosteroids; pred, predicted.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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and tiredness. They were further asked whether chemicals 
and scents induced airway symptoms (yes or no).
2.	 The CSS-SHR questionnaire was used to quantify affec-
tive and behavioral consequences of odor intolerance.12 
Selected from among a larger number of items about odor 
intolerance, the CSS-SHR consisted of eleven statements/
questions (Table 2) that are particularly sensitive for dis-
criminating SHR patients from controls. The unweighted 
sum of all eleven items makes up the individual’s total 
CSS-SHR score (ranging from 1–55 points; a high score 
indicating severe odor intolerance and $43 points is 
regarded as a cutoff value). A control group also answered 
the CSS-SHR questionnaire. It consisted of 29 subjectively 
healthy nonsmoking subjects (14 women and 16 men) aged 
between 48–76 years with a median age of 62 years. Sex and 
age of the control subjects did not differ from the patients. 
Controls were screened using questions on airway symp-
toms and symptoms in response to chemicals and scents. 
None of the controls had a history of allergy or symptoms 
in response to chemicals, scents, cold air, allergy, asthma, or 
COPD. No further medical examination was performed.
3.	 The Nottingham Health Profile measures “the subjective 
impact of disease” and was developed at Nottingham 
University.16,21–23 It consists of two parts, with part I con-
taining 38 statements categorized in six areas: physical 
mobility, pain, sleep disturbance, lack of energy, emo-
tional reaction, and social isolation. The questions are 
answered with yes or no, depending on whether it fits the 
individual’s current situation. Reference values for part I 
were developed by weighting each question, which means 
that positive responses to all questions within an area 
equals 100, and negative responses to all questions equals 
zero. The weighting procedure is based on Thurstone’s 
“paired comparison” method.24 For the total score on 
part I, or NHP total (the sum of questions 1–38 multiplied 
by their weights), the sum is divided by six to reach a 
value between zero and 100. NHP part II contains seven 
questions (yes or no) concerning the impact of health 
problems on the individual’s social function with regard 
to: paid employment, housework, social life, family life, 
sex life, hobbies, and holidays. For part II, the propor-
tion of positive responses for each of the seven questions 
was calculated separately and compared with the control 
group. Due to the age profile of the patients, the question 
regarding employment was excluded. The patients were 
encouraged to answer the questions based on how they 
felt during the last week. One basic rule for the NHP is 
that it must be self-administered.17
statistical methods
Median values and ranges were analyzed. Comparisons 
between patients and controls regarding the CSS-SHR 
questionnaire and within the COPD-group were performed 
with the Mann–Whitney U-test. For NHP part I, the Mann–
Whitney U-test was used for comparison of two independent 
groups, and for part II, Pearson’s chi-square test.
The work described in this article was carried out in 
accordance with World Medical Association’s Declaration of 
Helsinki: Ethical Principles for Medical Research   Involving 
Human Subjects.25 Informed consent was obtained from all 
patients at the start of the investigation, and the Regional 
Ethical Review Board of Gothenburg, Sweden approved 
the study.
Results
symptoms
Fifty patients (62%) claimed, by a yes answer, to have airway 
symptoms induced by chemicals and scents.
The patients’ symptom scores are described in Figure 1. 
The symptoms with the highest scores were heavy breathing, 
difficulty in getting air, and tiredness.
nHP
In part I, there was a significant deviation from the control 
group regarding energy, isolation, and mobility (P , 0.001) 
Table  2  Items  on  the  Chemical sensitivity scale  for sensory 
Hyperreactivity (Css-sHr)
 A.    I would not mind living on a street with odorous/pungent car 
exhausts if the apartment I had was nice.a
   B.     I am more aware of odorous/pungent substances than I used to be.a,b
  C.  At movies, other persons’ perfume and aftershave disturb me.a,b
D.  I am easily alerted by odorous/pungent substances.a,b
    e.    I get used to most odorous/pungent substances without much 
difficulty.a
  F.    How much would it matter to you if an apartment you were 
interested in renting was located close to a factory that emits 
odorous/pungent substances?b,c
g.   In public places, I do not mind some smell of cigarette smoke.a
H.    There are often times when I want a complete odor-free 
environment.a,b
    I.     I find it hard to relax in a place that evokes odor/pungent 
sensations.b,d
    J.   I would not mind living in an apartment that has a weak smell.a
 K.  I am sensitive to odorous/pungent substances.a,b
Notes:  ascale: agree strongly (0), agree (1), agree mildly (2), disagree mildly (3), 
disagree (4), disagree strongly (5). The numbers in parentheses refer to the score 
given for that response; bitem scored in opposite direction before responses are 
summed; cscale: it would completely deter me (0), or it would be very important (1), 
important (2), slightly important (3), or not important at all (4); dscale: always (0), 
very often (1), often (2), occasionally (3), seldom (4), never (5).International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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and from the total score (P , 0.01). Part II demonstrated 
a significant difference between the patient group and 
the control group for the question regarding housework 
(P , 0.001). There was no deviation between the patient and 
control groups with regard to family life, hobbies, holidays, 
and sex life.
Css-sHr
The patients’ median CSS-SHR score was 34 (11–51). Male 
patients did not differ from females. Patients with very 
severe COPD had significantly higher scores than patients 
with moderate COPD (P , 0.05). Among the controls, 
the median CSS-SHR value was 27 (11–44); this differed 
significantly from the results of the patients (P , 0.005) 
(Figure 2).
Differences between patients with high 
and low Css-sHr score
Twenty patients (25%) (twelve men and eight women) had a 
score of $43 points; thus exceeding the cutoff value for the 
score.12 The patients were divided into two groups according 
to the cutoff value: those who had a score of $43 points and 
those with lower scores.
There were more patients with a score of $43 points 
among patients with very severe COPD compared to those 
with moderate illness (P , 0.05) (Figure 3). High-scoring 
patients differed significantly from low-scoring partici-
pants regarding symptoms of heavy breathing (P , 0.01), 
  difficulty getting air (P , 0.001), chest pressure (P , 0.05), 
and hoarseness (P , 0.01). Patients with high scores   
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Figure 1 evaluation of seven symptoms on a scale of 0–3 (0 = no symptoms, 1 = mild symptoms, 2 = moderate symptoms, and 3 = severe symptoms) in 81 patients with 
chronic obstructive pulmonary disease.
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Figure 2 Mean Chemical sensitivity scale for sensory Hyperreactivity (Css-sHr) 
score (±	2 standard errors of the mean) in 81 chronic obstructive pulmonary disease 
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took β2-stimulants regularly (P , 0.05) more often than 
those with low scores.
For NHP part I, patients with a high CSS-SHR score 
differed significantly from low-scoring participants in the 
domains of energy (P , 0.05), mobility (P , 0.01), and 
with pain (P , 0.05).
Regarding age, sex, pack years, and treatment with 
inhaled steroids or anticholinergics, there were no differences 
between the low- and high-scoring groups. Further, there 
were no correlations between CSS-SHR scores and any use 
of medication among the patients.
Discussion
In summary, the results of this study illustrated that a majority 
(62%) of patients with COPD claimed to be hyperreactive 
to chemicals and scents. As a group they scored higher on 
a questionnaire measuring social and emotional influences 
of such environmental irritants compared to healthy control 
subjects (CSS-SHR questionnaire12). A potential bias is that 
only control subjects without any airway symptoms were 
included, but in a population-based study the prevalence of 
affective and behavioral consequences of odor intolerance 
(CSS-SHR score $ 43) was 19%,13 compared to 25% in the 
current study. However, the present number of patients in 
different age strata was too small to make proper   comparisons 
with the population-based results, which also included all 
categories of patients as well those with pronounced sensitiv-
ity to environmental irritants.
High-scoring patients were more common among patients 
with a very severe form of COPD and among patients with 
regular use of β2-stimulants. They also had significantly more 
airway symptoms and, in some aspects, greater impaired 
quality of life than those with low scores. This seems natural 
in light of their more severe pulmonary illness. On the other 
hand, increased sensitivity to odorous substances and chemi-
cals might contribute to the negative effects on quality of life 
noted in the NHP since SHR patients with a high CSS-SHR 
score, but without any decline of lung function, also have a 
reduced quality of life.22,26 There were no differences between 
men and women among the patients regarding the CSS-SHR 
questionnaire scores, and women were not more common 
in the high-scoring group. These findings are in contrast to 
earlier studies showing that in the Swedish population and in 
those with SHR, women scored higher on the CSS-SHR than 
men.12,13 In COPD, high CSS-SHR scores seem to be related 
to the basic pulmonary illness, and not influenced by sex.
Nonspecific airway responsiveness refers to the ease 
with which the airways narrow in response to nonallergic or 
nonsensitizing stimuli. Responsiveness can be measured by 
direct stimuli, like methacholine and histamine acting directly 
on the airway smooth muscles or by indirect stimuli like 
hypertonic saline, mannitol, exercise, and eucapnic hyper-
ventilation.27 Both in asthma and COPD, increased airway 
responsiveness to direct stimuli like methacholine is well-
known and documented. In COPD, this reaction is probably 
related to the patients’ basic airway limitation.27 On the other 
hand, responsiveness to indirect stimuli like hyperventilation 
is not as evident in COPD as in asthma.28
Patients with CPOD and asthma often complain about 
airway sensitivity to environmental irritants and such symp-
toms are often believed to be caused by hyperresponsiveness, 
meaning that airway narrowing follows irritation-induced 
airway symptoms. There are, however, few studies dealing 
with reactions from “real life” stimuli and if, for example, 
perfumed products can provoke bronchial obstruction in 
COPD, it is to our knowledge not known. In asthma, this 
knowledge is also limited.29,30 The fact still remains that 
patients claim to respond to such “trigger factors” and not 
to methacholine or hypertonic saline. Although the role of 
sensory nerves in airway inflammation and obstruction is 
controversial, there is a growing body of evidence for sensory 
nerves mediating many of the symptoms in these patients.31,32 
The current results are in line with a novel paradigm, the 
100%
80%
60%
40%
20%
0%
Low CSS-SHR
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score
n = 20
Very severe
Severe
Moderate
Mild
Figure 3 Comparison of the distribution of chronic obstructive pulmonary disease 
severity (mild, moderate, severe, very severe) in patients with low (,43 points, 
n = 61) or high Chemical sensitivity scale for sensory Hyperreactivity (Css-sHr) 
score (n = 20).International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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“cough hypersensitivity syndrome,” which includes patients 
with well-established airway diagnosis as well as patients 
with a general hypersensitivity towards environmental irri-
tants, indicating an airway “sensory neuropathy” in different 
patient groups.33,34
SHR patients have pronounced airway sensitivity to 
environmental irritants like odorous chemicals and scents, 
but without airflow obstruction, and they are also recognized 
by increased cough sensitivity to inhaled capsaicin;9–11 these 
two findings are regarded as closely related. Earlier studies 
reporting augmented capsaicin cough sensitivity in COPD,4,6 
together with the present results of subjective sensitivity in 
COPD, indicate that these two findings may be associated. To 
confirm such an association, capsaicin provocations need to 
be performed in COPD patients and related to the outcome 
of the CSS-SHR score. It is hypothesized that in line with 
increased capsaicin sensitivity in COPD, augmented sensory 
nerve reactivity develops together with more severe airway 
symptoms and impaired lung function. This SHR should 
be discriminated from airway hyperresponsiveness that is 
induced by direct or indirect stimuli. However, findings from 
an earlier study found that cough sensitivity to inhaled cap-
saicin was independent of the degree of airway obstruction 
in COPD, but the value of this report may be limited due to 
the small number of patients who were tested.4
In conclusion, the results of this study show that airway 
symptoms induced by environmental irritants are common in 
patients with COPD and that this increased airway sensitivity 
follows the impairment of lung capacity. The mechanisms 
behind this remain unclear.
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